查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403436

到 2030 年經皮貼片市場預測：按成分、應用、配銷通路和地區進行的全球分析

Transdermal Skin Patches Market Forecasts to 2030 - Global Analysis By Component, By Application, Distribution Channel and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球經皮皮膚貼片市場規模為 82 億美元，預計在預測期內將以 6.6% 的複合年成長率成長，到 2030 年達到 128 億美元。

經皮皮膚貼片是一種醫療設備，旨在將藥物透過皮膚輸送到血液中。該貼片由黏合劑、藥物儲存庫和控制膜等層組成，可提供受控和連續的藥物釋放。該貼片黏合在皮膚上，使藥物繞過消化系統直接被吸收到消化器官系統中。它為多種藥物提供了一種方便、非侵入性的遞送方法，並隨著時間的推移保持穩定的治療水平。

根據 GLOBOCAN 2020 報告，2020 年墨西哥報告了 195,499 例癌症病例，其中乳腺癌和前列腺癌是人群中最常見的癌症。

生長促進因素：與口服藥物相比，益處增加

人們越來越偏好經皮吸收貼片，因為它們比口服藥物具有明顯的優勢。這些貼片提供非侵入性藥物輸送，繞過消化器官系統並減少胃腸道副作用。確保藥物的穩定和受控釋放，保持一致的治療水準並提高患者的依從性。它非常方便，特別是對於長期治療，因為它需要較少的給藥次數並且易於給藥。此外，經皮吸收貼片緩解了與藥物在胃腸道分解相關的問題，提高了生物利用度，並為傳統口服藥物提供了一種有前途的替代品。

成長抑制因素：認知度低和產品成本上升

對經皮皮膚貼片缺乏認知和產品成本高是主要障礙。消費者和醫療保健專業人員對經皮吸收貼片的好處和用途了解不足可能會限制其採用。此外，配製和製造貼片的製造成本急劇上升，導致市場價格上漲，影響了一些患者的可及性。這些複雜的因素阻礙了廣泛的接受度和可負擔性，阻礙了這種有效的藥物傳遞系統在多種疾病狀態下的潛在用途。

機會：對處方經皮吸收貼片的需求不斷成長

對處方經皮吸收貼片不斷成長的需求為經皮皮膚貼片市場創造了巨大的機會。這種激增反映了人們對非口服給藥方法的偏好不斷變化以及對患者便利性的日益重視。隨著個人化醫療和標靶治療的轉變，對專門處方箋貼片的需求日益成長。它還正在推動研究改進貼片技術、擴大治療選擇並推動經皮藥物領域的市場成長。

威脅：皮膚吸收各種活性物質的能力受到限制

選擇性皮膚滲透性是經皮貼片面臨的挑戰。這種限制限制了適合經皮給藥的藥物範圍，並阻礙了特定治療方法的開發。此外，大分子、親水性化合物和具有特定化學性質的化合物難以有效穿過皮膚屏障，限制了適合經皮給藥的物質範圍。

COVID-19 的影響

COVID-19的爆發對經皮皮膚貼片市場產生了重大影響。對止痛藥和荷爾蒙療法等某些貼片的需求仍然強勁，但供應鏈和醫療保健的中斷影響了生產和分銷。封鎖也影響了患者就診，可能導致貼片使用者無法獲得新處方或定期檢查。然而，這場大流行凸顯了非侵入性給藥方法的重要性，並可能鼓勵未來經皮吸收貼片的進一步創新和廣泛普及。

預計在預測期內，黏合藥物領域將成為最大的領域

由於其主導地位，黏劑填充藥物領域預計將在預測期內主導市場。黏性藥物貼片將藥物直接融入黏膠層中，確保精確給藥並改善皮膚接觸。這種設計提供了方便、易於使用和穩定的藥物傳輸。此外，意外分層的風險也被降至最低。由於方便用戶使用的應用和可靠的藥物釋放曲線，藥物貼片預計將在未來仍然是首選，從而增加其在市場上的佔有率。

醫院藥房業務預計在預測期內複合年成長率最高

由於多種因素，醫院藥房業務預計將顯著成長。醫院在病患照護中發揮著至關重要的作用，也是藥物（包括經皮貼片）的主要分銷中心。需要長期用藥的慢性病的盛行率不斷上升，以及經皮給藥系統的採用率不斷上升，正在推動對醫院藥房的需求。此外，醫院內補丁的可用性和給藥的便利性也有助於市場的預期顯著成長。

比最大的地區

由於先進的醫療基礎設施、高昂的醫療成本以及對經皮傳輸系統技術進步的濃厚興趣，預計北美將引領經皮皮膚貼片市場。此外，患有慢性病的老年人口不斷增加以及文明病的流行正在推動對經皮吸收貼片的需求。此外，支持性的法律規範和主要市場參與者的強大影響力也有助於北美的優勢。

複合年成長率最高的地區

由於人口不斷增加、醫療保健意識不斷增強以及慢性病患病率不斷上升，預計亞太地區經皮貼劑配方市場將出現顯著成長。此外，醫療保健基礎設施的改善、向非侵入性治療的轉變以及推動醫療保健進步的新興國家的出現也為亞太地區的顯著成長做出了貢獻。此外，積極的政府措施和對改善醫療保健機會的關注也支持了該地區的市場擴張。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 公司之間的競爭關係

第5章全球經皮皮膚貼片市場：依成分分類

  • 水庫
  • 含黏合劑藥物
    • 單層
    • 多層
  • 矩陣
  • 微型針
  • 其他成分

第6章全球經皮皮膚貼片市場：依應用分類

  • 疼痛管理
  • 心血管疾病
  • 中樞神經系統疾病
  • 荷爾蒙治療
  • 神經系統疾病
  • 尼古丁戒菸
  • 膀胱過動症
  • 其他用途

第7章全球經皮皮膚貼片市場：按配銷通路

  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章全球經皮皮膚貼片市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • 4P Therapeutics
  • AdhexPharma
  • Aveva Drug Delivery Systems
  • Bayer AG
  • Corium, LLC
  • GlaxoSmithKline（GSK）
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Luye Pharma Group
  • Mundipharma
  • Mylan NV
  • Nitto Denko Corporation
  • Novartis
  • Pfizer Inc.
  • Praj HiPurity Systems Limited
  • ProSolus Pharmaceuticals
  • Sorrento Therapeutics Inc
  • Teva Pharmaceuticals
  • TheraDep Technologies
  • Transdermal Delivery Solutions Corporation
Product Code: SMRC24661

According to Stratistics MRC, the Global Transdermal Skin Patches Market is accounted for $8.2 billion in 2023 and is expected to reach $12.8 billion by 2030 growing at a CAGR of 6.6% during the forecast period. Transdermal skin patches are medical devices designed to deliver medication through the skin and into the bloodstream. Comprising layers including an adhesive, drug reservoir and a controlling membrane, these patches offer controlled, continuous drug release. They adhere to the skin, allowing drugs to be absorbed directly into circulation, bypassing the digestive system. They provide a convenient, non-invasive delivery method for various medications, maintaining steady therapeutic levels over time.

According to the GLOBOCAN 2020 report, 195,499 cancer cases were reported in Mexico in 2020, with breast and prostate cancers being the most common among the population.

Market Dynamics:

Driver:

Increasing advantages over the oral and ingesting medications

The rising preference for transdermal skin patches is fueled by their distinct advantages over oral medication. These patches offer non-invasive drug delivery, bypassing the digestive system and reducing gastrointestinal side effects. They ensure a steady, controlled release of medication, maintain consistent therapeutic levels and enhance patient compliance. With fewer dosing frequencies and simplified application, they provide convenience, especially for long-term therapies. Additionally, transdermal patches mitigate issues related to drug degradation in the digestive tract, improving bioavailability and offering a promising alternative to traditional oral medications.

Restraint:

Lack of awareness and elevated product costs

The limited awareness surrounding transdermal skin patches and their higher product costs pose significant restraints. Insufficient knowledge among consumers and healthcare professionals about their benefits and applications may limit their adoption. Moreover, elevated production expenses involved in formulating and manufacturing these patches contribute to higher market prices, impacting accessibility for some patients. These combined factors hinder widespread acceptance and affordability, impeding the potential utilization of this effective drug delivery system for various medical conditions.

Opportunity:

Growing need for prescription transdermal patches

The increasing demand for prescription transdermal patches presents a significant opportunity in the transdermal skin patch market. This surge reflects evolving preferences for non-oral drug delivery methods and a growing emphasis on patient convenience. With a shift toward personalized medicine and targeted therapies, the need for specialized, prescription-based patches is rising. It also fuels research into enhanced patch technologies, expanding treatment options and driving market growth in the transdermal medication sector.

Threat:

Skin's limited capacity to absorb various active substances 

The skin's selective permeability poses a challenge for transdermal patches, as not all substances can effectively penetrate its barriers. This limitation restricts the range of medications suitable for transdermal delivery, hindering the development of certain therapies. Additionally, large molecules, hydrophilic compounds and those with specific chemical properties struggle to traverse the skin barrier effectively, limiting the range of substances suitable for transdermal delivery.

COVID-19 Impact:

The COVID-19 pandemic has significantly influenced the transdermal skin patches market. While demand for certain patches, like those delivering pain relief or hormone therapies, remained steady, disruptions in supply chains and healthcare access impacted production and distribution. Lockdowns also affected patient consultations, potentially hindering new prescriptions and routine check-ups for patch users. However, the pandemic underscored the significance of non-invasive drug delivery methods, potentially driving further innovation and adoption of transdermal patches in the future.

The drug-in-adhesive segment is expected to be the largest during the forecast period

The drug-in-adhesive segment is expected to dominate the market during the forecast period due to its advantages. Drug-in-adhesive patches integrate the drug directly into the adhesive layer, ensuring precise dosing and enhanced skin contact. This design offers convenience, simplicity in application, and consistent drug delivery. Moreover, it minimizes the risk of accidental detachment. With its user-friendly application and reliable drug release profile, the drug-in-adhesive patch is anticipated to remain the preferred choice, fostering its prominence in the market.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is poised for significant growth due to various factors. Hospitals play a pivotal role in patient care and are key distribution points for pharmaceuticals, including transdermal patches. The increasing prevalence of chronic diseases requiring long-term medication, coupled with the rising adoption of transdermal drug delivery systems, is driving demand in hospital pharmacies. Additionally, the convenience of obtaining and administering patches within a hospital setting contributes to the projected substantial growth of the market.

Region with largest share:

North America is anticipated to lead the transdermal skin patches market due to its advanced healthcare infrastructure, high healthcare expenditure and robust focus on technological advancements in drug delivery systems. Additionally, a growing elderly population with chronic conditions, coupled with the prevalence of lifestyle-related diseases, fuels the demand for transdermal patches. Moreover, supportive regulatory frameworks and a strong presence of key market players contribute to North America's anticipated dominance.

Region with highest CAGR:

Asia Pacific is poised for notable growth in the transdermal skin patches market owing to the region's expanding population, rising healthcare awareness and increasing prevalence of chronic diseases. Moreover, improving healthcare infrastructure, a shift towards non-invasive treatments, and the presence of emerging economies fostering healthcare advancements contribute to the projected substantial growth in Asia Pacific. Additionally, supportive government initiatives and a focus on enhancing healthcare accessibility further propel market expansion in this region.

Key players in the market:

Some of the key players in transdermal skin patches market include 4P Therapeutics, AdhexPharma, Aveva Drug Delivery Systems, Bayer AG, Corium, LLC, GlaxoSmithKline (GSK), Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson, Luye Pharma Group, Mundipharma, Mylan N.V., Nitto Denko Corporation, Novartis, Pfizer Inc., Praj HiPurity Systems Limited, ProSolus Pharmaceuticals, Sorrento Therapeutics Inc, Teva Pharmaceuticals, TheraDep Technologies and Transdermal Delivery Solutions Corporation.

Key Developments:

In April 2023, researchers at MIT University developed a wearable patch that enables painless skin patch delivery. The patch utilizes painless ultrasonic waves to create tiny channels, allowing drugs to pass through the tough outer layer of the skin. This innovative approach holds the potential for delivering treatments for various skin conditions. This patch can also be adapted for delivering muscle relaxants, hormones, and other drugs.

In September 2022, Corium launched its Adlarity (donepezil transdermal system) for prescription use in the US Adlarity, a once-weekly patch, delivers consistent doses of donepezil through the skin. It could treat patients with mild, moderate, or severe dementia of Alzheimer's type.

In April 2022, Luye Pharma Group announced that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) had accepted the Marketing Authorization Application (MAA) for the company's investigational Rivastigmine Twice Weekly Transdermal Patch that was indicated for treating Alzheimer's disease of mild to moderate symptoms.

Components Covered:

  • Reservoir
  • Drug-in-Adhesive
  • Matrix
  • Microneedle
  • Other Components

Applications Covered:

  • Pain Management
  • Cardiovascular Disorders
  • Central Nervous System Disorders
  • Hormonal Therapy
  • Neurological Disorders
  • Nicotine Cessation
  • Overactive Bladder
  • Other Applications

Distribution Channels Covered:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transdermal Skin Patches Market, By Component

  • 5.1 Introduction
  • 5.2 Reservoir
  • 5.3 Drug-in-Adhesive
    • 5.3.1 Single Layer
    • 5.3.2 Multilayer
  • 5.4 Matrix
  • 5.5 Microneedle
  • 5.6 Other Components

6 Global Transdermal Skin Patches Market, By Application

  • 6.1 Introduction
  • 6.2 Pain Management
  • 6.3 Cardiovascular Disorders
  • 6.4 Central Nervous System Disorders
  • 6.5 Hormonal Therapy
  • 6.6 Neurological Disorders
  • 6.7 Nicotine Cessation
  • 6.8 Overactive Bladder
  • 6.9 Other Applications

7 Global Transdermal Skin Patches Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Online Pharmacies
  • 7.4 Retail Pharmacies

8 Global Transdermal Skin Patches Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 4P Therapeutics
  • 10.2 AdhexPharma
  • 10.3 Aveva Drug Delivery Systems
  • 10.4 Bayer AG
  • 10.5 Corium, LLC
  • 10.6 GlaxoSmithKline (GSK)
  • 10.7 Hisamitsu Pharmaceutical Co., Inc.
  • 10.8 Johnson & Johnson
  • 10.9 Luye Pharma Group
  • 10.10 Mundipharma
  • 10.11 Mylan N.V.
  • 10.12 Nitto Denko Corporation
  • 10.13 Novartis
  • 10.14 Pfizer Inc.
  • 10.15 Praj HiPurity Systems Limited
  • 10.16 ProSolus Pharmaceuticals
  • 10.17 Sorrento Therapeutics Inc
  • 10.18 Teva Pharmaceuticals
  • 10.19 TheraDep Technologies
  • 10.20 Transdermal Delivery Solutions Corporation

List of Tables

  • Table 1 Global Transdermal Skin Patches Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 4 Global Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 5 Global Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 6 Global Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 7 Global Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 8 Global Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 9 Global Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 10 Global Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 12 Global Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 13 Global Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 14 Global Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 15 Global Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 16 Global Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 17 Global Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 18 Global Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 19 Global Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 20 Global Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 21 Global Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 22 Global Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 23 North America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 25 North America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 26 North America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 27 North America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 28 North America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 29 North America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 30 North America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 31 North America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 32 North America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 North America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 34 North America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 35 North America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 36 North America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 37 North America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 38 North America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 39 North America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 40 North America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 41 North America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 42 North America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 43 North America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 44 North America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 45 Europe Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 47 Europe Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 48 Europe Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 49 Europe Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 50 Europe Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 51 Europe Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 52 Europe Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 53 Europe Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 54 Europe Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 55 Europe Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 56 Europe Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 57 Europe Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 58 Europe Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 59 Europe Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 60 Europe Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 61 Europe Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 62 Europe Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 63 Europe Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 64 Europe Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 65 Europe Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 66 Europe Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 67 Asia Pacific Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 Asia Pacific Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 69 Asia Pacific Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 70 Asia Pacific Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 71 Asia Pacific Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 72 Asia Pacific Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 73 Asia Pacific Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 74 Asia Pacific Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 75 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 76 Asia Pacific Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 Asia Pacific Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 78 Asia Pacific Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 79 Asia Pacific Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 80 Asia Pacific Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 81 Asia Pacific Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 82 Asia Pacific Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 83 Asia Pacific Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 84 Asia Pacific Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 85 Asia Pacific Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 86 Asia Pacific Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 87 Asia Pacific Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 88 Asia Pacific Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 89 South America Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 South America Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 91 South America Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 92 South America Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 93 South America Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 94 South America Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 95 South America Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 96 South America Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 97 South America Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 98 South America Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 99 South America Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 100 South America Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 101 South America Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 102 South America Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 103 South America Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 104 South America Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 105 South America Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 106 South America Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 107 South America Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 108 South America Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 109 South America Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 110 South America Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)
  • Table 111 Middle East & Africa Transdermal Skin Patches Market Outlook, By Country (2021-2030) ($MN)
  • Table 112 Middle East & Africa Transdermal Skin Patches Market Outlook, By Component (2021-2030) ($MN)
  • Table 113 Middle East & Africa Transdermal Skin Patches Market Outlook, By Reservoir (2021-2030) ($MN)
  • Table 114 Middle East & Africa Transdermal Skin Patches Market Outlook, By Drug-in-Adhesive (2021-2030) ($MN)
  • Table 115 Middle East & Africa Transdermal Skin Patches Market Outlook, By Single Layer (2021-2030) ($MN)
  • Table 116 Middle East & Africa Transdermal Skin Patches Market Outlook, By Multilayer (2021-2030) ($MN)
  • Table 117 Middle East & Africa Transdermal Skin Patches Market Outlook, By Matrix (2021-2030) ($MN)
  • Table 118 Middle East & Africa Transdermal Skin Patches Market Outlook, By Microneedle (2021-2030) ($MN)
  • Table 119 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Components (2021-2030) ($MN)
  • Table 120 Middle East & Africa Transdermal Skin Patches Market Outlook, By Application (2021-2030) ($MN)
  • Table 121 Middle East & Africa Transdermal Skin Patches Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 122 Middle East & Africa Transdermal Skin Patches Market Outlook, By Cardiovascular Disorders (2021-2030) ($MN)
  • Table 123 Middle East & Africa Transdermal Skin Patches Market Outlook, By Central Nervous System Disorders (2021-2030) ($MN)
  • Table 124 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hormonal Therapy (2021-2030) ($MN)
  • Table 125 Middle East & Africa Transdermal Skin Patches Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 126 Middle East & Africa Transdermal Skin Patches Market Outlook, By Nicotine Cessation (2021-2030) ($MN)
  • Table 127 Middle East & Africa Transdermal Skin Patches Market Outlook, By Overactive Bladder (2021-2030) ($MN)
  • Table 128 Middle East & Africa Transdermal Skin Patches Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 129 Middle East & Africa Transdermal Skin Patches Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 130 Middle East & Africa Transdermal Skin Patches Market Outlook, By Hospital Pharmacies (2021-2030) ($MN)
  • Table 131 Middle East & Africa Transdermal Skin Patches Market Outlook, By Online Pharmacies (2021-2030) ($MN)
  • Table 132 Middle East & Africa Transdermal Skin Patches Market Outlook, By Retail Pharmacies (2021-2030) ($MN)